a b s t r a c t NMDA receptors have an important role in pain facilitation in rostral ventromedial medulla (RVM) and the NR1 subunit is essential for its function. Studies suggest that the NMDA receptors in RVM are critical to modulate both cutaneous and muscle hypersensitivity induced by repeated intramuscular acid injections. We propose that increased expression of the NR1 subunit in the RVM is critical for the full development of hypersensitivity. To test this we used recombinant lentiviruses to over-express the NR1 subunit in the RVM and measured nociceptive sensitivity to cutaneous and muscle stimuli. We also downregulated the expression of NR1 in the RVM and measured the hyperalgesia produced by repeated-acid injections. Increasing the expression of NR1 in the RVM reduces cutaneous and muscle withdrawal threshold, and decreasing the expression of NR1 in the RVM increases the muscle withdrawal threshold and prevents the development of hyperalgesia in an animal model of muscle pain. These results suggest that the NR1 subunits in the RVM are critical for modulating NMDA receptor function, which in turn sets the 'tone' of the nervous system's response to noxious stimuli and tissue injury. Ó
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Introduction
Glutamate and its receptors in the brainstem play an important role in both inhibitory and facilitatory pathways of pain modulation. Injection of low doses of glutamate into the rostral ventromedial medulla (RVM) facilitates behavioral responses to noxious stimuli while high doses of glutamate inhibit behavioral responses to noxious stimuli [48, 49] . After injury, changes in the balance between facilitation and inhibition occur with enhanced facilitation thought to depend on glutamate binding to NMDA receptors. In animals with tissue injury, there is an enhanced release of glutamate in the RVM and an enhanced excitatory transmission of RVM neurons [27, 47] , which can be reversed by pharmacological blockade of NMDA receptors [47] . Pharmacological blockade of NMDA receptors in the RVM also reverses hyperalgesia produced by colon inflammation, nerve injury, or muscle pain induced by repeated-acid injections [8, 9, 40, 43] . Thus, the current data support a role for NMDA receptors in the facilitation of nociception within the RVM.
NMDA receptors are ionotropic channels, heteromers composed of NR1 and one or more of the four NMDA2 (NR2A-D) or two NMDA3 (NR3A and B) subunits [41] . The NR1 subunit is essential for the function of the NMDA receptors and phosphorylation of NR1 is a major mechanism of modulating channel activity and trafficking to the neuronal surface [5, 6] . In the spinal cord, downregulation of the NR1 subunits in the dorsal horn has no effect on baseline nociceptive responses in uninjured animals but prevents formalin or complete Freund's adjuvant (CFA)-induced nociceptive behaviors in inflammatory pain models [7, 14, 30, 35] . In the RVM, gene expression of NR1 is increased for 7 days after CFA-induced hindpaw inflammation [23] . Together, these data suggest an important role for the NR1 subunit in nociceptive processing particularly in the brain and spinal cord.
Our recent studies of muscle pain suggest that the RVM is a critical site to modulate both cutaneous and muscle hypersensitivity induced by repeated intramuscular acid injections. Anesthetic blockade in the RVM during the intramuscular injections prevents the development of both cutaneous and muscle hypersensitivity while both anesthetic blockade and NMDA receptor blockade in the RVM reverse the hypersensitivity once developed [9, 37] . Our model of deep tissue muscle pain is unique in that once developed, central mechanisms, not peripheral mechanisms, maintain the hyperalgesia [34, 37] . We propose that the NR1 subunit in the RVM is critical for full development of the hypersensitivity after 
